Trending stocks today
Parexel International Corp. (PRXL-Q)
0.00
Financials
Technical Analysis
$65.370
Owned
A contract research organization that basically takes outsourced clinical studies on behalf of pharmaceuticals, runs the studies through various phases on behalf of them. They have $5.4 billion of backlog. Have just gone through a restructuring process which will be additive in the last half of this year to their earnings.
- «
- ‹
- 1
- ›
- »
Parexel International Corp.(PRXL-Q) Rating
Ranking : 1 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 0
Parexel International Corp.(PRXL-Q) Frequently Asked Questions
What is Parexel International Corp. stock symbol?
Parexel International Corp. is a OTC stock, trading under the symbol PRXL-Q on the (). It is usually referred to as or PRXL-Q
Is Parexel International Corp. a buy or a sell?
In the last year, there was no coverage of Parexel International Corp. published on Stockchase.
Is Parexel International Corp. a good investment or a top pick?
Parexel International Corp. was recommended as a Top Pick by on . Read the latest stock experts ratings for Parexel International Corp..
Why is Parexel International Corp. stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Parexel International Corp. worth watching?
In the last year, there was no coverage of Parexel International Corp. published on Stockchase.
What is Parexel International Corp. stock price?
On , Parexel International Corp. (PRXL-Q) stock closed at a price of $.
(A Top Pick March 23/16. Up 9%.) Does clinical trials for the major drug producers, which is about 75% of their business. It’s been mildly disappointing. A very good company. They are growing their cash, which may lead to a dividend being paid in the near future. Very active in buying back shares. It has lots of potential.